Bill
SB 432
RELATING TO EQUITABLE GENDER REPRESENTATION ON CORPORATE BOARDS.
2025 Regular Session
Introduced by Carol Fukunaga and 3 co-sponsors
SB 432 classifies 7-Hydroxymitragynine as a Schedule I drug and imposes strict penalties for xylazine trafficking, enhancing Florida's controlled substances regulations.
Carried over to 2026 Regular Session.